{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:56:27Z","timestamp":1778788587704,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.prp.2017.10.023","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T01:35:08Z","timestamp":1509586508000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR)"],"prefix":"10.1016","volume":"214","author":[{"given":"Gabriella","family":"Gamberi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Benini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Resca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Magagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide Maria","family":"Donati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Righi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gambarotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.10.023_bib0005","series-title":"WHO Classification of Tumours of Soft Tissues and Bone","first-page":"321","article-title":"Giant cell tumor of bone","author":"Athanasou","year":"2013"},{"issue":"2","key":"10.1016\/j.prp.2017.10.023_bib0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3928\/01477447-20140124-08","article-title":"Giant cell tumor of bone","volume":"37","author":"Amanatullah","year":"2014","journal-title":"Orthopedics"},{"issue":"1","key":"10.1016\/j.prp.2017.10.023_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00428-009-0863-2","article-title":"Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone","volume":"456","author":"Alberghini","year":"2010","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2017.10.023_bib0020","series-title":"Diagnostic Pathology Bone","author":"Nielsen","year":"2013"},{"issue":"6","key":"10.1016\/j.prp.2017.10.023_bib0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00264-006-0215-7","article-title":"Giant cell tumour of bone: morphological, biological and histogenetical aspects","volume":"30","author":"Werner","year":"2006","journal-title":"Int. Orthop."},{"issue":"2","key":"10.1016\/j.prp.2017.10.023_bib0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhsa.2003.11.003","article-title":"Giant-cell tumor of the distal forearm","volume":"29","author":"Harness","year":"2004","journal-title":"J. Hand Surg. Am."},{"issue":"2","key":"10.1016\/j.prp.2017.10.023_bib0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11999-010-1501-7","article-title":"Giant cell tumor of bone: risk factors for recurrence","volume":"469","author":"Klenke","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.prp.2017.10.023_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00264-006-0204-x","article-title":"Histologically verified lung metastases in benign giant cell tumours-1 cases from a single institution","volume":"30","author":"Dominkus","year":"2006","journal-title":"Int. Orthop."},{"key":"10.1016\/j.prp.2017.10.023_bib0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1477-7819-12-261","article-title":"Pulmonary metastasis of giant cell tumor of bones","volume":"12","author":"Muheremu","year":"2014","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2017.10.023_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2017.10.023_bib0055","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/cncr.11359","article-title":"Malignancy in giant cell tumor of bone","volume":"97","author":"Bertoni","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2017.10.023_bib0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00428-012-1198-y","article-title":"Histological and clinical characteristics of malignant giant cell tumor of bone","volume":"460","author":"Gong","year":"2012","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.prp.2017.10.023_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00292-008-1090-3","article-title":"Differential diagnosis of giant cell-rich lesions of bone","volume":"29","author":"Lang","year":"2008","journal-title":"Pathologe"},{"issue":"12","key":"10.1016\/j.prp.2017.10.023_bib0070","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3\u2009B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2017.10.023_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics","volume":"16","author":"Presneau","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.prp.2017.10.023_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"29","author":"Wu","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2017.10.023_bib0085","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3 B as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2017.10.023_bib0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2017.10.023_bib0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jclinpath-2015-203248","article-title":"Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series","volume":"69","author":"Girolami","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2017.10.023_bib0100","first-page":"1","article-title":"Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone","volume":"25","author":"Ogura","year":"2017","journal-title":"Genes. Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.prp.2017.10.023_bib0105","doi-asserted-by":"crossref","first-page":"e36084","DOI":"10.1371\/journal.pone.0036084","article-title":"Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation","volume":"7","author":"Morandi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2017.10.023_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/humu.10228","article-title":"Enhanced allele-specific PCR discrimination in SNP genotyping using 3' locked nucleic acid (LNA) primers","volume":"22","author":"Latorra","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.prp.2017.10.023_bib0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.prp.2017.10.023_bib0120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/cr.2011.14","article-title":"The double face of the histone variant H3.3","volume":"21","author":"Szenker","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.prp.2017.10.023_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","article-title":"Giant cell tumor of the extremity: a review of 349 cases from a single institution","volume":"36","author":"Errani","year":"2010","journal-title":"Cancer Treat. Rev."},{"issue":"8","key":"10.1016\/j.prp.2017.10.023_bib0130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2017.10.023_bib0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3. 3 variant","volume":"71","author":"Luke","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2017.10.023_bib0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","article-title":"RANK (Receptor Activator of Nuclear Factor kappa B) and RANK ligand are expressed in giant cell tumors of bone","volume":"117","author":"Roux","year":"2002","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817308877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817308877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T06:02:00Z","timestamp":1535263320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817308877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0344033817308877"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.10.023","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR)","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}